Author:
Paul-Samojedny Monika,Pudełko Adam,Suchanek-Raif Renata,Kowalczyk Małgorzata,Fila-Daniłow Anna,Borkowska Paulina,Kowalski Jan
Publisher
Springer Science and Business Media LLC
Reference106 articles.
1. Weber GL, Parat M-O, Binder ZA, Gallia GL, Riggins GJ. Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells. Oncotarget. 2011;2:833–49.
2. Del Maestro R. Surgical resection and glioblastoma: molecular profiling and safety. Can J Neurol Sci. 2012;39:561–2.
3. Hafsi S, Pezzino FM, Candido S, Ligresti G, Spandidos DA, Soua Z, et al. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review). Int J Oncol. 2012;40:639–44.
4. Burris HA. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer Chemother Pharmacol. 2013;71:829–42.
5. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol. 2005;23:2411–22.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献